According to Harpoon Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 13.1852. At the end of 2023 the company had a P/S ratio of 0.4345.
Year | P/S ratio | Change |
---|---|---|
2023 | 0.4345 | -42.5% |
2022 | 0.7556 | -92.77% |
2021 | 10.5 | -57.04% |
2020 | 24.3 | -61.84% |
2019 | 63.8 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |